Plus, we note that GLP-1 drugs can increase a person’s risk of aspiration when ... The drugs whose labels were updated ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...

The South African Health Products Regulatory Authority (SAHPRA) has expressed concern at the increasing presence of counterfeit Glucagon-like Peptide (GLP-1) products, such as Ozempic, on the local ...

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Ozempic and Wegovy are GLP-1 receptor agonists. They mimic the hormone glucagon-like peptide-1, which affects the parts of ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

They mimic a natural hormone called GLP-1, which helps control insulin release, reduce hunger, and slow down digestion. These ...

Maryland’s policymakers should expand Medicaid coverage to include weight loss medications, writes Michelle Rogers.

In one hand, a slender young woman holds up a bottle of clear liquid. The words “Skinny” and “GLP-1” — a new class of weight loss drugs — are visible on the label. In the other hand, she raises up a ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...